Celgene Corp. to Announce Third Quarter 2017 Results on October 26, 2017; Will Host an Investor Webcast Event from the MSPari...
October 02 2017 - 7:30AM
Business Wire
Celgene Corporation (NASDAQ: CELG) will host a conference call
and live audio webcast on Thursday, October 26, 2017 at 9 a.m. ET
to discuss third quarter 2017 financial and operational results.
The webcast can be accessed from the Investor Relations page at
www.celgene.com.
Celgene will also host a webcast of an investor event at the
MSParis2017–7th Joint European Committee for Treatment and Research
in Multiple Sclerosis (ECTRIMS) – American Committee for Treatment
and Research in Multiple Sclerosis (ACTRIMS) Meeting on Saturday,
October 28 at 6:00 p.m. CEST (12:00 p.m. ET). Members of Celgene’s
management team and clinical investigators will discuss the data
presentations at the ECTRIMS Meeting. The event will be webcast
live and will be available in the Investor Relations section of the
Company’s web site at www.celgene.com.
About Celgene
Celgene Corporation, headquartered in Summit, New Jersey, is an
integrated global biopharmaceutical company engaged primarily in
the discovery, development and commercialization of innovative
therapies for the treatment of cancer and inflammatory diseases
through next-generation solutions in protein homeostasis,
immuno-oncology, epigenetics, immunology and neuro-inflammation.
For more information, please visit www.celgene.com. Follow Celgene
on Social Media: @Celgene, Pinterest, LinkedIn, Facebook and
YouTube.
Forward-Looking Statements
This press release contains forward-looking statements, which
are generally statements that are not historical facts.
Forward-looking statements can be identified by the words
"expects," "anticipates," "believes," "intends," "estimates,"
"plans," "will," “outlook” and similar expressions. Forward-looking
statements are based on management’s current plans, estimates,
assumptions and projections, and speak only as of the date they are
made. We undertake no obligation to update any forward-looking
statement in light of new information or future events, except as
otherwise required by law. Forward-looking statements involve
inherent risks and uncertainties, most of which are difficult to
predict and are generally beyond our control. Actual results or
outcomes may differ materially from those implied by the
forward-looking statements as a result of the impact of a number of
factors, many of which are discussed in more detail in our Annual
Report on Form 10-K and our other reports filed with the Securities
and Exchange Commission.
Hyperlinks are provided as a convenience and for informational
purposes only. Celgene bears no responsibility for the security or
content of external websites.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20171002005698/en/
Celgene CorporationPatrick E. Flanigan III,
908-673-9969Corporate VP, Investor RelationsorBrian Gill,
908-673-9530VP, Corporate Communications
Celgene (NASDAQ:CELG)
Historical Stock Chart
From Mar 2024 to Apr 2024
Celgene (NASDAQ:CELG)
Historical Stock Chart
From Apr 2023 to Apr 2024